Dr. Ken Harewood, GCM, formerly GlaxoSmithKline's Distinguished Professor, Director of the North Carolina Central University (NCCU) Julius L. Chambers Biomedical/Biotechnology Research Institute, and Adjunct Professor, Department of Molecular Genetics and Microbiology, Duke University, is widely recognized for his contribution in the areas of cancer biology and cancer drug discovery. Dr. Harewood received his secondary education at the Lodge School, Barbados, where in addition to academics, he excelled at soccer, becoming team captain and a member of the Barbados National Soccer Team. He attended New York University where he earned a Bachelor's degree in Biology. He received his Masters and Doctoral degrees in Biochemistry from City College of the City University of New York. After completing post-doctoral training at the New York Blood Center, Dr. Harewood joined the Central Research Division of Pfizer Inc. where he served as project leader in the Cancer Research Department and Principal Research Investigator in the Department of Molecular Genetics. Dr. Harewood's extensive corporate research experience resulted in creative contributions to national and international efforts that culminated in the discovery of the first human leukemia virus as well as the virus that causes AIDS. He conducted pioneering work on cloning the gene for bovine calf rennin leading to FDA approval of the first recombinant DNA process for a food ingredient. He also developed innovative cell-based strategies to facilitate the discovery of novel drugs to treat cancer. Dr. Harewood's high level of recognition is evidenced by the numerous honors and awards he received. These include: the Harlem YMCA Black Achievers in Industry Award; the National Consortium for Black Professional Development Health Sciences Award; the 1998 Barbados Charity Fund Pride and Industry Award; the 2006 North Carolina Central University Chancellor's Merit Award; the 2006 University of North Carolina Oliver Max Gardner Award; and the Barbados Gold Crown of Merit Award.